Academic Journal
Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)
| العنوان: | Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) |
|---|---|
| المؤلفون: | Charlotte E. Rinnooy Kan, Heike Röckmann, Marijke R. vanDijk, Tanuja Ramsaransing, Lieke L. Reubsaet, Elke E. M. Peters, Lydia E. Vos |
| المصدر: | JEADV Clinical Practice, Vol 3, Iss 1, Pp 275-279 (2024) |
| بيانات النشر: | Wiley, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Dermatology LCC:Diseases of the genitourinary system. Urology |
| مصطلحات موضوعية: | bullous cutaneous reaction, bullous eruption, COVID‐19 mRNA vaccination, Pfizer and Moderna COVID‐19 vaccination, reactive dermatitis, Dermatology, RL1-803, Diseases of the genitourinary system. Urology, RC870-923 |
| الوصف: | Abstract Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID‐19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID‐19 vaccination, respectively. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2768-6566 |
| Relation: | https://doaj.org/toc/2768-6566 |
| DOI: | 10.1002/jvc2.273 |
| URL الوصول: | https://doaj.org/article/6c493debc21b4dfab184b0e246550549 |
| رقم الانضمام: | edsdoj.6c493debc21b4dfab184b0e246550549 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 27686566 |
|---|---|
| DOI: | 10.1002/jvc2.273 |